Plasma miR-122 as a potential diagnostic and prognostic indicator in human glioma

scientific article published on 3 April 2017

Plasma miR-122 as a potential diagnostic and prognostic indicator in human glioma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S10072-017-2912-Y
P698PubMed publication ID28367610

P2093author name stringYing Tang
Dongfeng Li
Jiliang Wang
Yurong Tang
Qingbo Ren
Shunfeng Zhao
P2860cites workCirculating microRNAs as stable blood-based markers for cancer detectionQ24652098
The 2007 WHO classification of tumours of the central nervous systemQ24685772
MicroRNA signatures in human cancersQ27860962
MicroRNAs: genomics, biogenesis, mechanism, and functionQ27861070
MiR-122 inhibits cell proliferation and tumorigenesis of breast cancer by targeting IGF1R.Q34442762
Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemiaQ35857675
Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of gliomaQ36560956
MiR-122 targets VEGFC in bladder cancer to inhibit tumor growth and angiogenesisQ37144069
Genetics of adult gliomaQ38067239
MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung canerQ38738609
Decreased expression of microRNA-148a predicts poor prognosis in ovarian cancer and associates with tumor growth and metastasisQ38738742
WNT1 Gene from WNT Signaling Pathway Is a Direct Target of miR-122 in Hepatocellular CarcinomaQ38743109
The expression of miRNA-221 and miRNA-222 in gliomas patients and their prognosisQ38746253
Reduced expression of microRNA-497 is associated with greater angiogenesis and poor prognosis in human gliomasQ38749535
MiR-122/Wnt/β-catenin regulatory circuitry sustains glioma progressionQ38991254
Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.Q39217323
Circulating microRNA-196a/b are novel biomarkers associated with metastatic gastric cancerQ39598466
Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinomaQ39754560
Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancerQ40579865
Evaluation of miR-122 level in the plasma of chronically HCV infected patientsQ40653866
Upregulation of miR-183 expression and its clinical significance in human brain gliomaQ40740363
Identification and Evaluation of Serum MicroRNA-29 Family for Glioma ScreeningQ48466686
Plasma miR-454-3p as a potential prognostic indicator in human gliomaQ48563610
Plasma miR-221/222 Family as Novel Descriptive and Prognostic Biomarkers for Glioma.Q53624071
Overexpression of microRNA-155 predicts poor prognosis in glioma patients.Q55461092
Downregulation of microRNA-139 is associated with hepatocellular carcinoma risk and short-term survivalQ87319232
P433issue6
P304page(s)1087-1092
P577publication date2017-04-03
P1433published inNeurological SciencesQ15763262
P1476titlePlasma miR-122 as a potential diagnostic and prognostic indicator in human glioma
P478volume38

Reverse relations

cites work (P2860)
Q47226900Biomarkers in Spinal Cord Injury: from Prognosis to Treatment
Q64240657Clinical value of miRNA-122 in the diagnosis and prognosis of various types of cancer
Q104690914Comprehensive Characterization of Nanosized Extracellular Vesicles from Central and Peripheral Organs : Implications for Preclinical and Clinical Applications
Q60301685Liquid biopsy for pediatric central nervous system tumors
Q64899756MicroRNA based theranostics for brain cancer: basic principles.
Q50073558News on the journal Neurological Sciences in 2017.
Q92669998Serum exosomal miR-122 as a potential diagnostic and prognostic biomarker of colorectal cancer with liver metastasis
Q55456731microRNAs as potential biomarkers for the diagnosis of glioma: A systematic review and meta-analysis.

Search more.